tirzepatide patent expiration for Weight Loss As the patent for semaglutide,

One patient may have robust benefits, while another's insurance company denies coverage without strict criteria

Mechanistic Insights Semaglutide is a GLP-1 receptor agonist, mimicking the GLP-1 hormone to lower blood sugar by enhancing insulin release and slowing stomach emptying

As GLP-1s increasingly become associated with obesity treatment, it's easy to forget their original purpose: helping people with type 2 diabetes achieve better metabolic control and reduce long-term complications

Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment

Yes, severe or prolonged calorie deficits can reduce libido by disrupting sex hormone production, particularly testosterone and oestrogen